| Title: | Development of Novel ROCK Inhibitors via 3D-QSAR and Molecular Docking Studies: A Framework for Multi-Target Drug Design |
Authors: | Beljkaš, Milan   ; Petković, Miloš ; Vuletić, Ana ; Đurić, Ana ; Santibanez, Juan F. ; Srdić-Rajić, Tatjana ; Nikolić, Katarina ; Oljačić, Slavica |
Issue Date: | 2024 |
Publication: | Pharmaceutics |
ISSN: | 1999-4923 Pharmaceutics Search Idenfier |
Publisher: | Basel, Switzerland : Multidisciplinary Digital Publishing Institute (MDPI) |
Type: | Article |
Collation: | vol. 16 br. 10 str. 1250-1250 |
DOI: | 10.3390/pharmaceutics16101250 |
WoS-ID: | 001342843300001 |
Scopus-ID: | 2-s2.0-85207677039 |
PMID: | 39458584 |
PMCID: | PMC11514586 |
URI: | https://rimi.imi.bg.ac.rs/handle/123456789/1538
https://enauka.gov.rs/handle/123456789/944771
http://rimi.imi.bg.ac.rs/handle/123456789/1538
https://farfar.pharmacy.bg.ac.rs/handle/123456789/5817 |
Project: | Ministarstvo nauke, tehnološkog razvoja i inovacija Republike Srbije, institucionalno finansiranje - 200161 (Univerzitet u Beogradu, Farmaceutski fakultet)
Ministarstvo nauke, tehnološkog razvoja i inovacija Republike Srbije, institucionalno finansiranje - 200015 (Univerzitet u Beogradu, Institut za medicinska istraživanja) |
M-category: | |
